Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
GPR22 Biologics Sequence Review Report 2026: G protein-coupled receptor 22 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR22 Biologics Sequence Review Report 2026: G protein-coupled receptor 22 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR22 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR20 Biologics Sequence Review Report 2026: G protein-coupled receptor 20 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR20 Biologics Sequence Review Report 2026: G protein-coupled receptor 20 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR18 Biologics Sequence Review Report 2026: N-arachidonyl glycine receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR18 Biologics Sequence Review Report 2026: N-arachidonyl glycine receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR176 Biologics Sequence Review Report 2026: G protein-coupled receptor 176 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR176 Biologics Sequence Review Report 2026: G protein-coupled receptor 176 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR176 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR17 Biologics Sequence Review Report 2026: Uracil nucleotide/cysteinyl leukotriene receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR17 Biologics Sequence Review Report 2026: Uracil nucleotide/cysteinyl leukotriene receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR17 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR161 Biologics Sequence Review Report 2026: G protein-coupled receptor 161 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR161 Biologics Sequence Review Report 2026: G protein-coupled receptor 161 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR161 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR157 Biologics Sequence Review Report 2026: G protein-coupled receptor 157 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR157 Biologics Sequence Review Report 2026: G protein-coupled receptor 157 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR157 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR151 Biologics Sequence Review Report 2026: G protein-coupled receptor 151 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR151 Biologics Sequence Review Report 2026: G protein-coupled receptor 151 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR151 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR146 Biologics Sequence Review Report 2026: G protein-coupled receptor 146 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR146 Biologics Sequence Review Report 2026: G protein-coupled receptor 146 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR146 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR142 Biologics Sequence Review Report 2026: G protein-coupled receptor 142 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR142 Biologics Sequence Review Report 2026: G protein-coupled receptor 142 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR142 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR135 Biologics Sequence Review Report 2026: G protein-coupled receptor 135 Similarity and Patent-Risk Signals
8 min read
GPR135 Biologics Sequence Review Report 2026: G protein-coupled receptor 135 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR135 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR119 Biologics Sequence Review Report 2026: Glucose-dependent insulinotropic receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GPR119 Biologics Sequence Review Report 2026: Glucose-dependent insulinotropic receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of GPR119 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →